MedPath

MYLAN-ENTACAPONE

MYLAN-ENTACAPONE

Discontinued
DIN Number

02390337

Drug Class

Human

Market Date

Jul 31, 2012

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02390337
AIG Number0143623001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BX02 ENTACAPONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENTACAPONEActive
Strength: 200 MG
Monograph: ENTACAPONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.